This inventor holds 1 USPTO granted patent. Top assignee: Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Michèle Freche: Innovator in Apatite Ceramics
Introduction
Michèle Freche is a notable inventor based in Fonsegrives, France. He has made significant contributions to the field of materials science, particularly in the development of apatite ceramics for biological applications. His innovative approach has led to advancements that could benefit various medical fields.
Latest Patents
Freche holds a patent for a "Method for making apatite ceramics, in particular for biological use." This process involves the preparation of a homogeneous mixture of powders to form hydroxyapatite, which can be stoichiometric or non-stoichiometric. The method includes compacting the mixture under a pressure of 100 to 500 MPa at room temperature and subjecting it to hydrothermal treatment at low temperatures (100 to 500°C) in the presence of water within a sealed chamber. This innovative technique has the potential to enhance the performance of apatite ceramics in medical applications.
Career Highlights
Freche is associated with the Commissariat à l'Énergie Atomique, where he has been instrumental in research and development projects focused on advanced materials. His work has not only contributed to the scientific community but has also paved the way for practical applications in healthcare.
Collaborations
Throughout his career, Freche has collaborated with esteemed colleagues, including Joëlle Carpena and Benoît Donazzon. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Michèle Freche's contributions to the field of apatite ceramics exemplify the impact of innovative thinking in materials science. His patented methods and collaborative efforts continue to influence advancements in biological applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
